Clinical Trial Update: AIMSPRO in the Treatment of Bladder Dysfunction in Secondary Progressive Multiple Sclerosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for AIMSPRO evaluating treatment of bladder dysfunction in patients with Secondary Progressive Multiple Sclerosis. The status of t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progressive Multiple Sclerosis

Drugs mentioned

• AIMSPRO

Snippet

Sponsor: Daval International Limited | Conditions: Secondary Progressive Multiple Sclerosis | Phase 2 | Status: UNKNOWN